Evidence map›Paper›PMID 33705421›Full record

ArticlePloS one2021

Barriers and facilitators to use of a mobile HIV care model to re-engage and retain out-of-care people living with HIV in Atlanta, Georgia.

Michelle E Henkhaus, Sophia A Hussen, Devon N Brown, Carlos Del Rio, Michelle R Fletcher, Marxavian D Jones, Amulya Marellapudi, Ameeta S Kalokhe

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.0field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Acceptability, Facilitators, and Barriers of Long-Acting Injectable Cabotegravir/Rilpivirine Among Youth With HIV in the United States.The Journal of adolescent health : official publication of the Society for Adolescent Medicine · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Michelle E HenkhausDepartment of Global Health, Rollins School of Public Health, Emory University, Atlanta, Georgia, United States of America.ORCID 0000-0002-8525-6835
Sophia A HussenDepartment of Global Health, Rollins School of Public Health, Emory University, Atlanta, Georgia, United States of America.
Devon N BrownDepartment of Global Health, Rollins School of Public Health, Emory University, Atlanta, Georgia, United States of America.
Carlos Del RioDepartment of Global Health, Rollins School of Public Health, Emory University, Atlanta, Georgia, United States of America.
Michelle R FletcherDepartment of Global Health, Rollins School of Public Health, Emory University, Atlanta, Georgia, United States of America.
Marxavian D JonesDepartment of Global Health, Rollins School of Public Health, Emory University, Atlanta, Georgia, United States of America.ORCID 0000-0003-1468-8865
Amulya MarellapudiDepartment of Global Health, Rollins School of Public Health, Emory University, Atlanta, Georgia, United States of America.
Ameeta S KalokheDepartment of Global Health, Rollins School of Public Health, Emory University, Atlanta, Georgia, United States of America.ORCID 0000-0002-3556-1786
Emory University · US

Funding

Virology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Ann M Chahroudi, Colleen F Kelley · 2002 to 2026
$74.0M
NIAID NIH HHS P30 AI050409
6 · The paper itself

Abstract

Novel strategies to re-engage and retain people living with HIV (PLWH) who are out of care are greatly needed. While mobile clinics have been used effectively for HIV testing and linkage, evidence guiding their use in providing HIV care domestically has been limited. To guide the development of a mobile HIV clinic (MHC) model as a strategy to re-engage and retain PLWH who are out of care, we aimed to explore stakeholder perceptions of barriers and facilitators to MHC implementation and use. From June 2019-July 2020, we conducted 41 in-depth interviews with HIV clinic providers, administrators, staff, legal authorities, and community advisory board members, PLWH, AIDS service organizations and city officials in Atlanta, Georgia, and domestic and international mobile health clinics to explore barriers and facilitators to use of MHCs. Interviews were transcribed, coded and thematically analysed. Barriers raised include potential for: breach of confidentiality with resulting heightened stigmatization, fractured continuity of care, safety concerns, staffing challenges, and low community acceptance of MHC presence in their locality. Participants provided suggestions regarding appropriate exterior design, location, timing, and co-delivery of non-HIV services that could facilitate MHC acceptance and address the concerns. In identifying key barriers and facilitators to MHC use, this study informs design and implementation of an MHC as a novel strategy for re-engaging and retaining PLWH who are out of care.

Indexed as

AdultAmbulatory Care FacilitiesAnti-HIV AgentsConfidentialityContinuity of Patient CareFemaleGeorgiaHealth Services AccessibilityHIV-1HIV InfectionsHumansMaleMiddle AgedMobile Health UnitsPatient Acceptance of Health CarePatient DropoutsAnti-HIV Agents

Identifiers

PMID33705421
PMCPMC7951832
OpenAlexW3134965427

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.